If you think GENZ is headed higher click

If you think GENZ is headed lower click

GENZ

Genzyme Corporation

Recent Community Picks
JPM BCON PFE FSLR FCX ISF UAUA TZA	NFLX AAPL STI GS GLD IBM ORCL SHLD

Last Trade: 70.64
%Change: +0.24%
Volume Analysis
Average Volume: 5074890
Half Hour Run Rate: 390376
1 Minute Run Rate: 13012
Run Rate Based: 3838540
Current Volume: 3703488
P/E: N/A
Market Cap: 18.002B
52 Week High: 71.01
52 Week Low: 45.39
Next Year EPS: 3.55
Twitter Updates: GENZ

GENZ - Genzyme Corporation

Genzyme Corporation (Genzyme) is a biotechnology company. Genzyme operates in four segments: Genetic Diseases, Cardiometabolic and Renal, Biosurgery and Hematologic Oncology. Genetic Diseases unit develops, manufactures and distributes therapeutic products, with a focus on products to treat patients suffering from genetic diseases and other chronic debilitating diseases, including a family of diseases known as lysosomal storage disorders (LSDs). Cardiometabolic and Renal segment develops, manufactures and distributes products that treat patients suffering from renal diseases, including chronic renal failure and endocrine and cardiovascular diseases. Biosurgery segment develops, manufactures and distributes biotherapeutics and biomaterial-based products, with a focus on products that meet medical needs in the orthopaedics and broader surgical areas. Hematologic Oncology segment develops, manufactures and distributes products for the treatment of cancer.

Derivatives Risk Management

© Big Moving Stock About | Disclaimer | Advertise | User Manual